Ikena Oncology
Industry
- Biotechnology
- Pharmacogenetics-Pharmacogenomics
- Pharmaceuticals
- Vaccines
Other Names/Subsidiaries
- Arrys Therapeutics
- Kyn Therapeutics
- Pionyr Immunotherapeutics
Latest on Ikena Oncology
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With UK’s Alchemab On A
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli
With the impact of biosimilar competition for Humira (adalimumab) playing out as expected, AbbVie Inc. is expanding its offerings in inflammatory bowel disease (IBD), with the acquisition of Celsiu
Insmed Incorporated , Structure Therapeutics, Inc. and Merus N.V. raised more than $1.5bn combined in recent follow-on public offerings (FOPOs), taking advantage of a spike in investor interest an